Trimebutine ( DrugBank: Trimebutine )


1 disease
IDDisease name (Link within this page)Number of trials
51Scleroderma1

51. Scleroderma


Clinical trials : 523 Drugs : 608 - (DrugBank : 156) / Drug target genes : 114 - Drug target pathways : 215
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000026859
2017/04/1005/04/2017Effectiveness of therapy with acotinamide hydrochloride and Trimebutine Maleateon gastro-oesophagial disease in systemic sclerosis systemic sclerosisacotinamaide hydrpchloride
100 mg tablets, 3 times/day, 28 days
trimebutine maleateon
100 mg tablets, 3 times/day, 28 days
Third Department of Internal Medicine (Department of Rheumatology) Shimane University Faculty of MedicineJapanese Cross Society Matsue JCS HospitalShimane Prefecture central HospitalPending20years-oldNot applicableMale and Female40Phase 3Japan